SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-049324
Filing Date
2019-09-09
Accepted
2019-09-09 16:30:58
Documents
5
Period of Report
2019-09-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-18411_18k.htm 8-K 32399
2 EX-10.1 a19-18411_1ex10d1.htm EX-10.1 6074
3 EX-99.1 a19-18411_1ex99d1.htm EX-99.1 11751
4 GRAPHIC g184111ksi001.jpg GRAPHIC 3779
5 GRAPHIC g184111mmi001.jpg GRAPHIC 2610
  Complete submission text file 0001104659-19-049324.txt   60637
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 191083358
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1